Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
CMO Council to Team With Chief Marketer Network on Strategic Thought Leadership Initiatives in 2026
-
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Rexel: Denial of rumors regarding Rexel acquisition
-
Cannabliss Innovates with Custom Packaging Solutions for the Cannabis Industry
-
Form 8.3 - 1Spatial Plc
-
Southern Michigan Bancorp, Inc. Declares Cash Dividend
-
Form 8.3 - Frenkel Topping Group Plc
-
Form 8.3 - Inspecs Group Plc
-
Jeffs’ Brands: KeepZone AI Successfully Completes Live Pilot Demonstrating Checkpoint-Free Weapon Screening at High-Profile Event
-
MiddleGround Capital Completes Sale of Lindsay Precast to TJC
-
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
-
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy
-
Alliance Police Department Commits to Non-Lethal Response with Full BolaWrap® 150 Rollout
-
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
-
Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board
-
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
-
Valour Inc. Launches Constant Leveraged Bitcoin and Ethereum ETPs on Spotlight Stock Market
-
NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries
-
Terra Innovatum Advances NRC Licensing of SOLO™ Reactor Licensing Through Expanded Regulatory Submissions
-
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
-
Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates
-
Bombardier Announces $500 Million Debt Repayment and Confirms Deleveraging Plan on Target
-
Renowned AI Expert Xi Chen Joins Compass Lexecon
-
Nayax Partners with Unipaas to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms
-
Unipaas Partners with Nayax to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms
-
Xeronum Emerges to Power the Next Wave of Digital Experiences
-
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
-
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
-
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
-
AZI Plans to Subscribe for US$100 Million of Token Cat Limited Shares at US$30 per Share, Strengthening Automotive Group-Buying Channels and Supporting AZI’s Global Expansion Strategy
-
Wallbridge Announces its 2026 Exploration Program and Budget
-
ExGen Signs Binding LOI to Acquire Silver Stream on Past-Producing Gold Mine
-
MADD Canada Urges Canadians to Plan Ahead and Drive Sober This Holiday Season
-
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
-
Abcourt Presents Operations Update for November 2025 in the Development of the Sleeping Giant Mine
-
Abaxx Calls Warrants, Provides Corporate Update
-
Xali Gold to Close First Tranche of Private Placement December 19, 2025
-
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome
-
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
-
EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
-
Akamai and Visa Join Forces to Secure the Next Era of Agentic Commerce
-
Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases
-
Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, January 8, 2026
-
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
-
New Book Helps Close the Leadership Gap in Crisis Readiness
-
Bitcoin Munari Confirms Final Presale at $0.015 With No Further Rounds Planned
